Drug intelligence / Profile preview

Chlorhexidine + metronidazole

Development stage
Unknown
Lead developer
AkzoNobel
Modality
Small Molecules
Administration
Topical
01

Overview

Chlorhexidine + metronidazole is a combination medication primarily used for treating oral and gum infections. This combination leverages the antiseptic properties of chlorhexidine gluconate and the antibiotic action of metronidazole to effectively combat bacterial infections in the mouth. ## Mechanism of Action This combination works through dual mechanisms: 1. **Chlorhexidine Gluconate**: Acts as an antiseptic and disinfectant by binding to the surface of teeth, inner cheeks, and gums. This kills infectious microorganisms that cause gum disease, tartar, and other mouth infections[1][3]. 2. **Metronidazole**: Functions as an antibiotic that kills bacteria and other infectious microorganisms by damaging their DNA[1][3]. ## Uses The primary uses of chlorhexidine + metronidazole include: - Treatment of mouth infections and associated symptoms like ulcers and swelling[1] - Management of gingivitis and periodontitis[2][6] - Control of dental plaque and tartar[6] - Treatment of bad breath (halitosis)[6] - Post-dental surgery infection prevention[6] - Oral ulcer and sore treatment[6] ## Available Formulations This combination is available in various forms including: - Oral gels - Mouthwashes - Dental treatments ## Brand Names Several pharmaceutical companies manufacture this combination under different brand names including: - Septacare-M - Metzine - Hygina - Fogum - Orahex M - Dentonex M - Metrohex - Orex M - Metrolite DG - Metroross DG Forte[1] ## Side Effects Common side effects of chlorhexidine + metronidazole include: - Bitter taste - Staining of teeth and tongue - Altered taste sensation - Oral irritation - Dryness in the mouth - Nausea and vomiting[1][3] ## Clinical Evidence Research has shown that the combination of chlorhexidine and metronidazole can be effective in treating gingivitis. Studies have demonstrated significant improvements based on microbiological and clinical assessments, which has reduced the need for surgical treatments of gingiva and supporting structures[2]. Recent reports indicate that combining silver nanoparticles with chlorhexidine and metronidazole produces excellent bacteriostatic and bactericidal effects, showing promising results for future treatment approaches[5].

Brand names
Septacare-MMetzineHyginaFogumOrahex MDentonex MMetrohexOrex MMetrolite DGMetroross DG Forte
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Chlorhexidine + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chlorhexidine + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call